एपीए उद्धरण

Chen, Y. H., Claflin, K., Geoghegan, J. C., & Davidson, B. L. (2012). Sialic Acid Deposition Impairs the Utility of AAV9, but Not Peptide-modified AAVs for Brain Gene Therapy in a Mouse Model of Lysosomal Storage Disease. Nature Publishing Group.

शिकागो स्टाइल उद्धरण

Chen, Yong Hong, Kristin Claflin, James C. Geoghegan, और Beverly L. Davidson. Sialic Acid Deposition Impairs the Utility of AAV9, but Not Peptide-modified AAVs for Brain Gene Therapy in a Mouse Model of Lysosomal Storage Disease. Nature Publishing Group, 2012.

एमएलए उद्धरण

Chen, Yong Hong, Kristin Claflin, James C. Geoghegan, और Beverly L. Davidson. Sialic Acid Deposition Impairs the Utility of AAV9, but Not Peptide-modified AAVs for Brain Gene Therapy in a Mouse Model of Lysosomal Storage Disease. Nature Publishing Group, 2012.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.